These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 3781947)
1. VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways. Palmer JB; Cuss FM; Barnes PJ J Appl Physiol (1985); 1986 Oct; 61(4):1322-8. PubMed ID: 3781947 [TBL] [Abstract][Full Text] [Related]
2. Comparison of vasoactive intestinal peptide and isoproterenol relaxant effects in isolated cat airways. Altiere RJ; Diamond L J Appl Physiol Respir Environ Exerc Physiol; 1984 Apr; 56(4):986-92. PubMed ID: 6725078 [TBL] [Abstract][Full Text] [Related]
3. Is peptide histidine isoleucine an inhibitory nonadrenergic noncholinergic neurotransmitter in the rat gastric fundus? D'Amato M; Currò D; Ciabattoni G; Lefebvre RA Arch Int Pharmacodyn Ther; 1990; 303():216-31. PubMed ID: 1973609 [TBL] [Abstract][Full Text] [Related]
4. The effects of vasoactive intestinal peptide (VIP) antagonists, and VIP and peptide histidine isoleucine antisera on non-adrenergic, non-cholinergic relaxations of tracheal smooth muscle. Ellis JL; Farmer SG Br J Pharmacol; 1989 Mar; 96(3):513-20. PubMed ID: 2720290 [TBL] [Abstract][Full Text] [Related]
5. Peptide histidine methionine and vasoactive intestinal peptide: occurrence and relaxant effect in the human female reproductive tract. Palle C; Ottesen B; Jørgensen J; Fahrenkrug J Biol Reprod; 1989 Dec; 41(6):1103-11. PubMed ID: 2624870 [TBL] [Abstract][Full Text] [Related]
6. Effects of peptidases on non-adrenergic, non-cholinergic inhibitory responses of tracheal smooth muscle: a comparison with effects on VIP- and PHI-induced relaxation. Ellis JL; Farmer SG Br J Pharmacol; 1989 Mar; 96(3):521-6. PubMed ID: 2655804 [TBL] [Abstract][Full Text] [Related]
7. Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in human and bovine pulmonary arteries. Greenberg B; Rhoden K; Barnes PJ Blood Vessels; 1987; 24(1-2):45-50. PubMed ID: 3567364 [TBL] [Abstract][Full Text] [Related]
8. Modulation of cholinergic neurotransmission by vasoactive intestinal peptide and peptide histidine isoleucine in guinea-pig tracheal smooth muscle. Ellis JL; Farmer SG Pulm Pharmacol; 1989; 2(2):107-12. PubMed ID: 2562470 [TBL] [Abstract][Full Text] [Related]
9. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP. Watanobe H; Tamura T J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939 [TBL] [Abstract][Full Text] [Related]
10. Effects of VIP and PHM in human intracervical arteries. Hansen V; Ottesen B; Allen J; Maigaard S; Forman A Acta Obstet Gynecol Scand; 1988; 67(8):699-701. PubMed ID: 3250182 [TBL] [Abstract][Full Text] [Related]
11. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. Ward JK; Belvisi MG; Fox AJ; Miura M; Tadjkarimi S; Yacoub MH; Barnes PJ J Clin Invest; 1993 Aug; 92(2):736-42. PubMed ID: 8349813 [TBL] [Abstract][Full Text] [Related]
12. Effect of the neuropeptides vasoactive intestinal peptide, peptide histidine methionine and substance P on human major salivary gland secretion. Del Fiacco M; Quartu M; Ekström J; Melis T; Boi M; Isola M; Loy F; Serra MP Oral Dis; 2015 Mar; 21(2):216-23. PubMed ID: 24725136 [TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM) in human penile corpus cavernosum tissue and circumflex veins: localization and in vitro effects. Kirkeby HJ; Fahrenkrug J; Holmquist F; Ottesen B Eur J Clin Invest; 1992 Jan; 22(1):24-30. PubMed ID: 1348474 [TBL] [Abstract][Full Text] [Related]
14. Anomalous growth hormone response to vasoactive intestinal peptide and peptide histidine methionine in patients with prolactinoma or hypothalamic hyperprolactinemia. Watanobe H; Tamura T; Takahashi K Neuropeptides; 1994 Aug; 27(2):137-42. PubMed ID: 7991068 [TBL] [Abstract][Full Text] [Related]
15. Relaxation of isolated guinea pig trachea, bronchi and pulmonary arteries produced by vasoactive intestinal peptide (VIP). Hand JM; Laravuso RB; Will JA Eur J Pharmacol; 1984 Feb; 98(2):279-84. PubMed ID: 6714311 [TBL] [Abstract][Full Text] [Related]
16. Relaxant effect of rat PHI, PHI-Gly and PHV(1-42) in the rat gastric fundus. Lefebvre RA; Sas S; Cauvin A Peptides; 1991; 12(2):271-4. PubMed ID: 1648712 [TBL] [Abstract][Full Text] [Related]
17. A further study on the stimulatory effect of peptide histidine methionine on growth hormone secretion in acromegaly: a dose-related study and a comparison with vasoactive intestinal peptide. Watanobe H; Takebe K Neuropeptides; 1992 Oct; 23(2):115-9. PubMed ID: 1333573 [TBL] [Abstract][Full Text] [Related]
18. Inhibition by L-NG-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airway. Ellis JL; Undem BJ Am Rev Respir Dis; 1992 Dec; 146(6):1543-7. PubMed ID: 1456572 [TBL] [Abstract][Full Text] [Related]
19. Peptide histidine isoleucine and vasoactive intestinal polypeptide cause relaxation of opossum internal anal sphincter via two distinct receptors. Nurko S; Dunn BM; Rattan S Gastroenterology; 1989 Feb; 96(2 Pt 1):403-13. PubMed ID: 2535995 [TBL] [Abstract][Full Text] [Related]
20. The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans. Barnes PJ; Dixon CM Am Rev Respir Dis; 1984 Aug; 130(2):162-6. PubMed ID: 6465669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]